BTC$65,925.00+0.15%
ETH$1,796.55+2.02%
USDT$0.999-0.04%
BNB$608.02-0.69%
XRP$1.22-0.34%
USDC$0.9998+0.00%
SOL$73.83+0.77%
TRX$0.3172-0.07%
FIGR_HELOC$1.04+0.77%
HYPE$74.66+7.58%
DOGE$0.0876+0.96%
USDS$0.9996-0.01%
LEO$9.57-1.77%
RAIN$0.0141+3.20%
ZEC$511.72-1.74%
XLM$0.2255+6.79%
BTC$65,925.00+0.15%
ETH$1,796.55+2.02%
USDT$0.999-0.04%
BNB$608.02-0.69%
XRP$1.22-0.34%
USDC$0.9998+0.00%
SOL$73.83+0.77%
TRX$0.3172-0.07%
FIGR_HELOC$1.04+0.77%
HYPE$74.66+7.58%
DOGE$0.0876+0.96%
USDS$0.9996-0.01%
LEO$9.57-1.77%
RAIN$0.0141+3.20%
ZEC$511.72-1.74%
XLM$0.2255+6.79%
Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments, identifying two promising drug targets using AI technology.